bioAffinity Technologies, Inc. , a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics.
Bioaffinity Technologies stock last closed at $0.24, down 1.22% from the previous day, and has decreased 84.39% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.57 percentage points. Bioaffinity Technologies stock is currently +47.56% from its 52-week low of $0.16, and -89.29% from its 52-week high of $2.26.
There are currently 28.47M shares of BIAF outstanding. The market value of BIAF is $6.89M. In the last 24 hours, 169,000 BIAF shares were traded.
You need an online brokerage account to access the NASDAQ market and buy BIAF stock.
Based on our analysis, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, it's time to fill out some personal details so you can invest in BIAF today.
Now that you have filled out your info on one of the best stock market apps, you need to deposit funds:
Watch this video walkthrough to see the process of depositing funds into your investment account.
Once you have figured out the best place to buy Bioaffinity Technologies stock, it's critical to evaluate their stock before you invest, so you truly wrap your head around the risk as well as the opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on BIAF's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge BIAF's intrinsic value.
You can do more valuation analysis on BIAF's stock here.
Last year, BIAF revenue was $7.68M. In the past 3 year, BIAF's revenue has gone up by 1,804.96% per year. This was faster than the Diagnostics & Research industry average of 9.61%.
Dig into BIAF's earnings and revenue performance here.
In the past year, insiders at BIAF have not bought or sold any shares.
Learn more about who owns BIAF shares here.
No, Bioaffinity Technologies doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two main options:
Click the Open Trade button and your broker will execute your order.
If you need additional help investing in stocks on eToro, click the how to video below:
Now that you own some BIAF stock, you'll want to stay up-to-date on your investment.
Start a watchlist to track the most important metrics related to your BIAF stock.
To reiterate, here are the 6 steps for buying Bioaffinity Technologies stock:
If you need a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get updates on your investment in Bioaffinity Technologies, add BIAF to your watchlist below.